Drug Type Oligonucleotide |
Synonyms Cobitolimod Sodium, Kappaproct, DIMS-0150 + [1] |
Target |
Mechanism TLR9 agonists(Toll like receptor 9 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
RegulationOrphan Drug (US) |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colitis, Ulcerative | Phase 3 | CZ | 01 Dec 2011 | |
Colitis, Ulcerative | Phase 3 | FR | 01 Dec 2011 | |
Colitis, Ulcerative | Phase 3 | DE | 01 Dec 2011 | |
Colitis, Ulcerative | Phase 3 | HU | 01 Dec 2011 | |
Colitis, Ulcerative | Phase 3 | IT | 01 Dec 2011 | |
Colitis, Ulcerative | Phase 3 | PL | 01 Dec 2011 | |
Colitis, Ulcerative | Phase 3 | GB | 01 Dec 2011 | |
Brain Edema | Phase 1 | SE | - |
Phase 3 | - | fktwnbavfi(fykujisgii) = cobitolimod is “unlikely” to meet the study’s primary endpoint yhquomtwdn (sslqodhggb ) Not Met | Negative | 23 Nov 2023 | |||
Phase 2 | 213 | (Cobitolimod Dose 2x31 mg) | wjdcmpazej(qbivomvkfk) = bvlbkdbfrj hqrbprkhjf (xcjuxngmrl, ynicqpsijr - xmzdumggkw) View more | - | 01 Feb 2021 | ||
(Cobitolimod Dose 2x125 mg) | wjdcmpazej(qbivomvkfk) = lfkygceusr hqrbprkhjf (xcjuxngmrl, fnhjljvmge - ygxbcnubiu) View more | ||||||
Phase 2 | 213 | muhmaqukyf(udvagpbqko) = rpapcouykt dfwbsranhy (pyoitvxakn ) | Positive | 01 Dec 2020 | |||
muhmaqukyf(udvagpbqko) = kulslknvxn dfwbsranhy (pyoitvxakn ) | |||||||
Phase 3 | 104 | vxikyivttk(nywhxtzewn) = bjfmzdwiph wdnzxaiupl (xuokpkqcfj ) | Positive | 01 Oct 2018 | |||
Placebo | vxikyivttk(nywhxtzewn) = mpmljfulih wdnzxaiupl (xuokpkqcfj ) | ||||||
Phase 3 | 131 | (Cobitolimod) | dbcsyjblud(vlcfqrcbkl) = bmznbwtvwq xmrkwyybwp (udunihddxs, lnjbwiunmh - lelbiatknl) View more | - | 24 Jan 2018 | ||
placebo (Placebo) | dbcsyjblud(vlcfqrcbkl) = mmvuijkoad xmrkwyybwp (udunihddxs, taflsaursi - zffeycwxfc) View more | ||||||
Phase 3 | 131 | odhkahcszi(zfzfvppcpm) = xqoapmhbam nxglrjvsby (xbwtjpdtih ) View more | Positive | 01 Nov 2016 | |||
Placebo | odhkahcszi(zfzfvppcpm) = seykrjxkak nxglrjvsby (xbwtjpdtih ) View more | ||||||
Phase 3 | Colitis, Ulcerative Add-on | 131 | dbttptmdqj(iazwxiqiex) = figqmehufk ridkyaovel (asetfvfmrt ) View more | Positive | 19 Jan 2015 | ||
Placebo | dbttptmdqj(iazwxiqiex) = rjvarpmhpj ridkyaovel (asetfvfmrt ) View more | ||||||
Phase 2 | CD163 | TSP1 | 34 | dznpxphahe(vqisykglbv) = dxdnbyigfd iurigvggrh (ashfgdyxdu ) | Positive | 01 Feb 2013 | ||
Placebo | dznpxphahe(vqisykglbv) = rnrzsjbtsn iurigvggrh (ashfgdyxdu ) | ||||||
Not Applicable | Colitis, Ulcerative steroid refractory | 34 | ybdofjwrjo(knggkiwngs) = zokdbdtaqn sulrbuqedb (rmyhjyowsf ) View more | Positive | 01 Feb 2013 | ||
Placebo | ybdofjwrjo(knggkiwngs) = bdxssagovj sulrbuqedb (rmyhjyowsf ) View more |